Monday, September 12, 2016

Water for Injections BP 2ml, 5ml, 10ml & 20ml





1. Name Of The Medicinal Product



Water for Injections B.P. 2ml, 5ml, 10ml & 20ml.


2. Qualitative And Quantitative Composition



Each 1ml of solution contains 1ml of Water for Injections B.P.



3. Pharmaceutical Form



Clear, colourless, odourless, sterile solution intended for parenteral administration to human beings.



4. Clinical Particulars



4.1 Therapeutic Indications



For the reconstitution, dilution and making-up of appropriate drugs where Water for Injections is the diluent of choice, and for use as an irrigant.



4.2 Posology And Method Of Administration



Route of administration: For S.C., I.M. or IV. injection, or as appropriate to the reconstituted drug.



Dosage: In accordance with the particular situation for which Water for Injections B.P. is being used.



4.3 Contraindications



None known.



4.4 Special Warnings And Precautions For Use



None.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



None known.



4.6 Pregnancy And Lactation



May be used during this period.



4.7 Effects On Ability To Drive And Use Machines



None.



4.8 Undesirable Effects



None known.



4.9 Overdose



No effects anticipated with the proposed use.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Not applicable.



5.2 Pharmacokinetic Properties



Not applicable.



5.3 Preclinical Safety Data



No further relevant information other than that which is included in other sections of the Summary of Product Characteristics.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Not applicable.



6.2 Incompatibilities



Water for Injections B.P. should not be mixed with any other agents unless their compatibility has been established.



6.3 Shelf Life



3 years.



6.4 Special Precautions For Storage



Do not store above 25°C.



6.5 Nature And Contents Of Container



2ml, 5ml, 10ml and 20ml hermetically sealed translucent plastic ampoules, polypropylene Ph.Eur., packed in cardboard cartons to contain 10, 20, 50 and 100 ampoules.



6.6 Special Precautions For Disposal And Other Handling



For S/C, I/M or I/V Injection or as appropriate to the reconstituted drug.



If only part of an ampoule is used, discard the remaining solution.



Use as directed by the physician.



Keep out of reach of children.



7. Marketing Authorisation Holder



Antigen International Ltd.,



Roscrea,



Co. Tipperary,



Ireland.



8. Marketing Authorisation Number(S)



PL 2848/0152.



9. Date Of First Authorisation/Renewal Of The Authorisation



Date of first authorization : 10/10/91.



10. Date Of Revision Of The Text



August 2001




No comments:

Post a Comment